Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does cyclooxygenase-2 affect blood pressure?

Hui-Fang Cheng1, Raymond C Harris

  • 1Division of Nephrology, S 3223 MCN, Vanderbilt University School of Medicine, Nashville, TN 37232-2372, USA. Huifang.Cheng@vanderbilt.edu

Current Hypertension Reports
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dehydration promotes intracellular lipid synthesis and accumulation.

Nature communications·2026
Same author

The Role of the Epidermal Growth Factor Receptor in Kidney Tubulointerstitial Fibrosis.

Seminars in nephrology·2026
Same author

Discoidin Domain Receptor 1 Translocation to the Mitochondria Promotes Oxidative Stress and Apoptosis in Acute Kidney Injury.

Journal of the American Society of Nephrology : JASN·2026
Same author

K<sub>ir</sub>5.1-modulated potassium flux stimulates an anabolic kidney phenotype.

iScience·2025
Same author

Use of Bayesian decision analysis in the design of patient-centered clinical trials for kidney failure devices.

Computers in biology and medicine·2025
Same author

EGF Receptor Activation Stimulates SOX9 Expression in Injured Renal Proximal Tubule Epithelial Cells.

Journal of the American Society of Nephrology : JASN·2025
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

New cyclooxygenase (COX)-2 inhibitors require careful safety evaluation. These drugs may affect kidney function and blood pressure, particularly in vulnerable patients.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Cyclooxygenase (COX)-2 is constitutively expressed in the kidney.
  • COX-2 plays a role in regulating renal blood flow, renin release, and sodium excretion.
  • The clinical use of COX-2 inhibitors raises safety concerns regarding renal function and blood pressure.

Purpose of the Study:

  • To review the safety profile of COX-2 inhibitors.
  • To examine the effects of COX-2 inhibition on renal function and blood pressure.
  • To identify patient populations requiring special caution.

Main Methods:

  • Literature review of studies on COX-2 inhibitors.
  • Analysis of data on renal and cardiovascular effects.
  • Clinical safety considerations.

Related Experiment Videos

Main Results:

  • COX-2 inhibition can lead to modest blood pressure elevations in some individuals.
  • COX-2 inhibitors may worsen pre-existing hypertension or interact with antihypertensive medications.
  • Patients with volume depletion or compromised organ perfusion are at higher risk.

Conclusions:

  • COX-2 inhibitors may impact renal function and blood pressure.
  • Caution is advised in patients with specific risk factors.
  • Further research on long-term safety is warranted.